Wed November 30th, 2016
Aptamers Market - Strong Trend of R&D Investments in Biotechnology and Pharmaceutical Companies.
Download FREE PDF Brochure@ http://tinyurl.com/hkdegov Aptamers can be generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. These can be used as pharmaceutical leads, detection reagents, and functional proteomic levels (with small molecules, antibodies, or other aptamers). The scope of this market report includes DNA-, RNA-, and XNA-based aptamers used for research applications. The major drivers for the market include a strong trend of R&D investments in biotechnology and pharmaceutical industries, patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies. Scope- Global Aptamers Market, by Type DNA-Based Aptamers RNA-Based Aptamers XNA-Based Aptamers Global Aptamers Market, by Application Diagnostics Therapeutics Development Research and Development Other Applications Global Aptamers Market, by Technology SELEX Other Technologies Global Aptamers Market, by End User Academic and Government Research Institutes Biotechnology and Pharmaceutical Companies Contract Research Organizations Other End Users Global Aptamers Market, by Geography Americas U.S. Canada Latin America Europe Asia Rest of the World The major players in aptamers market include AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences, Inc. (South Korea), Aptamer Solutions Ltd. (U.K.), Aptus Biotech S.L. (Spain), Base Pair Biotechnologies, Inc. (U.S.), NeoVentures Biotechnology, Inc. (Canada), SomaLogic, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), and Vivonics, Inc. (U.S.).